BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 83 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,513,868 | -8.8% | 1,076,603 | +3.9% | 0.01% | 0.0% |
Q2 2023 | $17,013,617 | -2.9% | 1,036,152 | -1.2% | 0.01% | 0.0% |
Q1 2023 | $17,526,061 | +15.0% | 1,048,836 | +6.2% | 0.01% | 0.0% |
Q4 2022 | $15,236,878 | -29.3% | 987,484 | -31.6% | 0.01% | -28.6% |
Q3 2022 | $21,562,000 | -1.0% | 1,444,255 | +9.0% | 0.01% | 0.0% |
Q2 2022 | $21,776,000 | -15.0% | 1,325,413 | +3.8% | 0.01% | 0.0% |
Q1 2022 | $25,606,000 | -20.8% | 1,276,486 | +0.2% | 0.01% | -12.5% |
Q4 2021 | $32,323,000 | +2.5% | 1,274,547 | +9.0% | 0.01% | +14.3% |
Q3 2021 | $31,544,000 | -1.5% | 1,169,164 | +5.6% | 0.01% | 0.0% |
Q2 2021 | $32,017,000 | +10.9% | 1,107,099 | +0.9% | 0.01% | 0.0% |
Q1 2021 | $28,859,000 | +27.3% | 1,097,284 | +38.7% | 0.01% | +40.0% |
Q4 2020 | $22,662,000 | +64.6% | 790,968 | +37.0% | 0.01% | +25.0% |
Q3 2020 | $13,770,000 | +170.1% | 577,362 | +136.8% | 0.00% | +300.0% |
Q2 2020 | $5,099,000 | +103.6% | 243,865 | +74.3% | 0.00% | 0.0% |
Q1 2020 | $2,504,000 | – | 139,875 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |